Aadi Bioscience: Drug Recall
Recall #D-0059-2023 · 10/13/2022
Class III: Low Risk
Recall Details
- Recall Number
- D-0059-2023
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Aadi Bioscience
- Status
- Terminated
- Date Initiated
- 10/13/2022
- Location
- Pacific Palisades, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,333 vials
Reason for Recall
Failed Stability Specifications
Product Description
Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.
Distribution Pattern
Within the U.S Market - PA, AL, KY, TN
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.